OPTN (optinose.com) Koefisien nilai perusahaan marang pendapatan

OptiNose (OPTN) - logo korporat

The EV/Sales multiple trend confirms the prudent strategy of OptiNose, Inc. (OPTN) management to expand niche sales and their transparent engagement with insurers. The current metric holds at , which correlates with a stable balance sheet and sufficient capital for all operational needs. An innovative nasal delivery system, available for broad licensing to various partners, provides high growth potential.

OPTN optinose.com: Rasio nilai perusahaan marang pendapatan ing interval 04.07.2022 - 20.11.2026

OPTN (OptiNose Corp): rincian analitis lan laporan miturut indikator

- kuotasi lan prakiraan analis:
- indikator valuasi pasar bisnis:
Pambiji fundamental perusahaan:OPTN, OptiNose
Barang utama Optinose

This indicator determines the total enterprise value, including debt and cash, relative to annual revenue to identify the actual overvaluation of the asset. By analyzing the EV/Sales ratio, an investor can gauge the monetization efficiency of the OptiNose, Inc. (OPTN) pharmaceutical ecosystem, where high patient loyalty to the drug delivery system and FDA patent protection establish a foundation for revenue growth.

Pesaing langsung

HLN: Rasio nilai perusahaan marang pendapatan|Kenvue Corp (KVUE) - Rasio nilai perusahaan marang pendapatan|Verona Pharma PLC - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Jyong Biotech Ltd|Multiplikator EV/Sales Ligand Corp|Multiplikator EV/Sales AMRX|Rasio total nilai perusahaan marang pendapatan Perrigo Company plc|Multiplikator EV/Sales ALVO (Alvotech Biopharmaceuticals)|LQDA: Rasio nilai perusahaan marang pendapatan|Galapagos N.V. - Multiplikator EV/Sales|ANIP - Multiplikator EV/Sales|MNKD: Multiplikator EV/Sales|amphastar.com (AMPH) - Multiplikator EV/Sales|PCRX (Pacira Pharmaceuticals) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan ARS Pharmaceuticals, Inc. (SPRY)|Multiplikator EV/Sales TBPH|AQST (Aquestive Therapeutics) - Nilai bisnis marang pendapatan|scPharmaceuticals, Inc. - Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan TECX|tonixpharma.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan BioHarvest|Nilai perusahaan marang pendapatan EXOZ|Nilai perusahaan marang pendapatan Oramed Pharmaceuticals (ORMP)|Nilai perusahaan marang pendapatan ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABVC (ABVC BioPharma Inc)|CPIX - Nilai perusahaan marang pendapatan|Quantum BioPharma Corp - Multiplikator EV/Sales|FGEN (fibrogen.com) - Rasio nilai perusahaan marang pendapatan|TELO (Telomir Pharmaceuticals) - Nilai perusahaan marang pendapatan|Rani Therapeutics Holdings - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan SNYR|Multiplikator nilai perusahaan marang pendapatan rallybio.com RLYB|Multiplikator EV/Sales LEXX|PULM (Pulmatrix, Inc.) - Nilai bisnis marang pendapatan|Pheton Holdings - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales Aptorum Group Limited APM|LYRA: Nilai perusahaan marang pendapatan|IBO: Rasio nilai perusahaan marang pendapatan|TNFA: Multiplikator EV/Sales|YCBD: Koefisien nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan PainReform Ltd|CYTO (altamiratherapeutics.com) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIPO|PIRS (Pieris Pharma) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Procaps Group S.A. PROC|Rasio total nilai perusahaan marang pendapatan petrospharma.com (PTPI)|QLI - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan SLRN (ACELYRIN)|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan